אירינוטקאן זריקות 20 מ"ג/מ"ל

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

IRINOTECAN (TRIHYDRATE) HYDROCHLORIDE 20 MG/ML

Pieejams no:

NOVAPHARMA LTD

ATĶ kods:

L01XX19

Zāļu forma:

CONCENTRATE FOR SOLUTION FOR INFUSION

Ievadīšanas:

I.V

Ražojis:

HOSPIRA AUSTRALIA PTY LTD

Ārstniecības grupa:

IRINOTECAN

Ārstēšanas norādes:

Irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. For the treatment of patients with small cell lung cancer. For the treatment of patients with gastric cancer.

Autorizācija datums:

2012-11-01